Carolyn Compton, MD, PhD

Medical director

Carolyn Compton is an academic pathologist specializing in gastrointestinal disease and is board certified in both anatomic and clinical pathology.

She is a professor in the School of Life Sciences at ASU and a professor of laboratory medicine and pathology at Mayo Clinic. She is also an adjunct professor of pathology at both the University of Arizona and Johns Hopkins University. She is the chief medical officer of the National Biomarker Development Alliance, a member of the Biodesign Institute at ASU.

Joshua L. LaBaer, MD, PhD

Laboratory director

Joshua LaBaer is a leading researcher in cancer and personalized medicine and is the executive director for the Biodesign Institute at ASU.

He is one of the nation’s foremost investigators in the rapidly expanding field of personalized diagnostics. His efforts focus on the discovery and validation of biomarkers — unique molecular fingerprints of disease — which can provide early warning for those at risk of major illnesses, including cancer and diabetes. In 2017, LaBaer was appointed executive director of the Biodesign Institute at ASU. There he guides talented researchers who are pioneering a dynamic new academic research model that embodies a hub for 21st century innovation.

Vel Murugan, PhD, MBA

Program and technical director

Vel Murugan is a leading molecular biologist with extensive experience in diagnostic test development with an emphasis on quality assurance and quality control.

He is an associate research professor at the Biodesign Virginia G. Piper Center for Personalized Diagnostics. His contributions have been instrumental in developing an RNA biomarker-based high-throughput ARad radiation biodosimetry test. His current research focuses on an epigenetic biomarker-based diagnostic test to detect exposure to weapons of mass destruction, funded by the DARPA ECHO program.